FDA 483 - OU Health - October 28, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of OU Health, an HCT/Ps manufacturer in Oklahoma City, revealed a significant compliance issue regarding donor eligibility documentation. The firm failed to ensure that HCT/Ps were accompanied by a statement confirming donor eligibility was based on screening and testing results. Specifically, their 'HPC Donor Eligibility / Suitability Summary Record' did not explicitly state that eligibility decisions were derived from a review of screening and testing outcomes.
ID · 1b424429-11e9-4cd6-8183-0eda01029d19